102 related articles for article (PubMed ID: 7922982)
1. Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Gallee MP; Hart AA; Müller M; Trimbos JB; Helmerhorst TJ
Cancer; 1994 Oct; 74(8):2307-13. PubMed ID: 7922982
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patients with cervical carcinoma.
Baay MF; Duk JM; Burger MP; Walboomers J; ter Schegget J; Groenier KH; de Bruijn HW; Stolz E; Herbrink P
J Clin Pathol; 1995 May; 48(5):410-4. PubMed ID: 7629285
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
[TBL] [Abstract][Full Text] [Related]
4. Serum antibody against unfused recombinant E7 protein of human papillomavirus type 16 in cervical cancer patients.
Fujii T; Matsushima Y; Yajima M; Sugimura T; Terada M
Jpn J Cancer Res; 1995 Jan; 86(1):28-34. PubMed ID: 7737906
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
Gynecol Oncol; 2002 May; 85(2):333-8. PubMed ID: 11972397
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
Nindl I; Benitez-Bribiesca L; Berumen J; Farmanara N; Fisher S; Gross G; Lopez-Carillo L; Müller M; Tommasino M; Vazquez-Curiel A
Arch Virol; 1994; 137(3-4):341-53. PubMed ID: 7524466
[TBL] [Abstract][Full Text] [Related]
7. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.
Onda T; Kanda T; Zanma S; Yasugi T; Watanabe S; Kawana T; Ueda K; Yoshikawa H; Taketani Y; Yoshiike K
Int J Cancer; 1993 Jun; 54(4):624-8. PubMed ID: 8390409
[TBL] [Abstract][Full Text] [Related]
8. Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies.
Baay MF; Duk JM; Groenier KH; Burger MP; de Bruijn HW; Hollema H; Stolz E; Herbrink P
Cancer Immunol Immunother; 1997 Jun; 44(4):211-5. PubMed ID: 9222279
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma.
Baay MF; Duk JM; Burger MP; de Bruijn HW; Stolz E; Herbrink P
J Med Virol; 1995 Mar; 45(3):342-7. PubMed ID: 7775959
[TBL] [Abstract][Full Text] [Related]
10. Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer.
Kanda T; Onda T; Zanma S; Yasugi T; Furuno A; Watanabe S; Kawana T; Sugase M; Ueda K; Sonoda T
Virology; 1992 Oct; 190(2):724-32. PubMed ID: 1325704
[TBL] [Abstract][Full Text] [Related]
11. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L
Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer.
Heim K; Widschwendter A; Pirschner G; Wieland U; Awerkiew S; Christensen ND; Bergant A; Marth C; Höpfl R
Am J Obstet Gynecol; 2002 Apr; 186(4):705-11. PubMed ID: 11967495
[TBL] [Abstract][Full Text] [Related]
13. E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Spector ME; Sacco AG; Bellile E; Taylor JMG; Jones T; Sun K; Brown WC; Birkeland AC; Bradford CR; Wolf GT; Prince ME; Moyer JS; Malloy K; Swiecicki P; Eisbruch A; McHugh JB; Chepeha DB; Rozek L; Worden FP
Clin Cancer Res; 2017 Jun; 23(11):2723-2729. PubMed ID: 27872102
[No Abstract] [Full Text] [Related]
14. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
[TBL] [Abstract][Full Text] [Related]
15. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls.
Köchel HG; Monazahian M; Sievert K; Höhne M; Thomssen C; Teichmann A; Arendt P; Thomssen R
Int J Cancer; 1991 Jul; 48(5):682-8. PubMed ID: 1649138
[TBL] [Abstract][Full Text] [Related]
17. Detection of antibodies to the E4 or E7 proteins of human papillomaviruses (HPV) in human sera by western blot analysis: type-specific reaction of anti-HPV 16 antibodies.
Jochmus I; Bouwes Bavinck JN; Gissmann L
Mol Cell Probes; 1992 Aug; 6(4):319-25. PubMed ID: 1326715
[TBL] [Abstract][Full Text] [Related]
18. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
Sasagawa T; Inoue M; Tanizawa O; Yutsudo M; Hakura A
Jpn J Cancer Res; 1992 Jul; 83(7):705-13. PubMed ID: 1325428
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population.
Müller M; Viscidi RP; Ulken V; Bavinck JN; Hill PM; Fisher SG; Reid R; Munoz N; Schneider A; Shah KV
J Invest Dermatol; 1995 Jan; 104(1):138-41. PubMed ID: 7798632
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later.
Lehtinen M; Pawlita M; Zumbach K; Lie K; Hakama M; Jellum E; Koskela P; Luostarinen T; Paavonen J; Pukkala E; Sigstad E; Thoresen S; Dillner J
Am J Obstet Gynecol; 2003 Jan; 188(1):49-55. PubMed ID: 12548195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
